ETFsXtrackers MSCI World Information Technology UCITS ETF 1C
Xtrackers
Xtrackers MSCI World Information Technology UCITS ETF 1C
XDWT LSEAccumulatingIreland
Last close · EUR
125.94EUR
-4.54% · -€5.99
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XDWTBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +17.4%
- Sharpe 3Y
- 1.09
- Volatility 1Y
- 22.4%annualised
- Holdings
- 132Fund holdings
Performance
Compare
- XDWT+17.4%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XDWT | -6.1% | +6.1% | +17.9% | +25.3% | +17.4% | +121.3% | +129.2% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -6.5% | +1.2% | +7.1% | +9.0% | +1.5% | +45.7% | +57.9% |
Risk and return
Sharpe ratio · 3Y
1.09
Below MSCI World · 1.24- Return p.a.
- +28.6%
- Volatility
- 22.9%
- Max loss
- -29.7%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
XDWT
1.09
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 69.0%
- Holdings
- 132
- As of
- 1APPLEUS037833100518.91%
- 2NVIDIAUS67066G104017.58%
- 3MICROSOFTUS594918104513.76%
- 4BROADCOM INCUS11135F10125.51%
- 5MICRON TECHNOLOGYUS59511210383.73%
- 6ADVANCED MICRO DEVICESUS00790310783.07%
- 7ASML HOLDINGNL00102732152.29%
- 8CISCO SYSTEMS INCUS17275R10231.54%
- 9PALANTIR TECHNOLOGIES CLASS AUS69608A10881.50%
- 10APPLIED MATERIAL INCUS03822210511.16%
Countries
Classified 100.0%
United States90.1%
JP
NL
- Largest
- 90.1%United States
- Top 3
- 96.3%
- Effective number
- 1.21 / HHI
Market cap
Weight vs holdings
69.0%of the fund sits in the top 10 holdings
69.0%22.8%
WeightHoldings
104082
- Holdings 1-10
- Holdings 11-50
- Holdings 51-132
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
